AACR AACR Presentations Highlight Power of Large Tumor Atlases in Studies of Cancer Progression Premium The talks focused on studies stemming from the Cancer Moonshot initiative's Human Tumor Atlas Network project, which is readying its first data release. Startup OncXerna Therapeutics Explores Tumor Microenvironment to Help Guide Cancer Treatment Premium The Boston-based firm recently shared data indicating its RNA-seq panel can help guide colorectal cancer treatment with its in-licensed investigational drugs. Biodesix's Proteomic Method for Predicting Immunotherapy Response Advancing Toward Market Premium The firm will commercialize its Primary Immune Response assay as a laboratory-developed test to help guide immunotherapy decisions in lung cancer patients. Grail Cancer Early Detection Test Performance Holds Steady as Q2 Launch Approaches Premium Recent results from the firm's case-control study cohort showed overall sensitivity of about 50 percent but higher performance for a subset of high-mortality cancers. Guardant AACR Data Highlights Value of Clinical Test Database to Drive Drug Resistance Discoveries Researchers used the company's large clinical-genomic database to characterize HRD reversion mutations and explore their potential function in patient resistance to PARP inhibitors. Apr 12, 2021 Oncocyte AACR Data Expands Potential Applications for Immunotherapy Response Predictor Apr 11, 2021 NCI Director Sharpless Outlines Ideas to Aggressively Lower Cancer Deaths Jun 26, 2020 Brain, Kidney Cancer Studies Lay Path for Clinical Application of Epigenetic Liquid Biopsy Method Premium Jun 26, 2020 Dana-Farber Team Reports Progress With Precision Oncology Trial Matching Software Jun 25, 2020 At AACR, Stanford Team Shares Single-Cell Fusion Detection Tool For Mapping Tumor Cells Jun 25, 2020 Inivata Demonstrates Potential of ctDNA Assay for Cancer Recurrence, MRD Applications Premium Jun 24, 2020 Nationwide Children's Reports High Diagnostic Yield of Combined DNA, RNA Analysis in Pediatric Cancers Jun 23, 2020 Advanced CRISPR Screens Uncover Possible Novel Targets for Cancer Therapies Premium Jun 23, 2020 Patient-Specific ctDNA Detection Method Could Improve MRD Monitoring for Cancer Recurrence Premium Jun 22, 2020 MSK Researchers Find High Prevalence of Germline Mutations in Patients With Early-Onset Cancers Apr 30, 2020 TMB Harmonization Data Extends Concordance Findings, Tests Calibration Methods Apr 30, 2020 New TraceRx Data Adds Evidence for Adjuvant Liquid Biopsy Minimal Residual Disease Testing Premium Apr 29, 2020 Pan-Cancer Screening Tests Report First Performance Numbers in Undiagnosed Cohorts Premium Apr 29, 2020 Normal Breast Cell Types, States Characterized by Single-Cell Transcriptome Analysis Apr 28, 2020 New Iteration of AACR's Project GENIE Focuses on Real-World Outcomes to Enhance Precision Oncology Premium Apr 23, 2020 Inivata Expects New Minimal Residual Disease, Recurrence Assay to Support Pharma Trials Premium Feb 5, 2020 Methylation, Fragmentation Analyses Remain at Forefront of Early Detection Liquid Biopsy Development Premium Jan 23, 2020 Viral Cancer Early Detection Efforts Making Progress Toward the Clinic Premium Dec 12, 2019 Immunotherapy Regimens Yield Contrasting Results in Early Triple Negative Breast Cancer Premium Apr 22, 2019 Researchers Seek Best Approach to Identify Lung Cancer Patients With MET-Based Resistance Premium Load More Breaking News JP Morgan, Cowen Initiate Coverage of Singular Genomics Systems Top Five Articles on GenomeWeb Last Week: Danaher, Becton Dickinson, 23andMe, and More Berry Oncology, Alibaba Health Partner to Offer Early Cancer Screening, Health Services Roche Receives FDA EUA for PCR-Based, Point-of-Care SARS-CoV-2 Test Decode Study Identifies Proteomic Predictors of All-Cause Mortality In Brief This Week: Natera, Bruker, Bayer, and More The Scan Renewed Gain-of-Function Worries The New York Times writes that the pandemic is renewing concerns about gain-of-function research. Who's Getting the Patents? A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports. Other Uses CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2. PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.